Identification and partial characterization of differentially expressed mRNAs in normal human endometria and endometrial carcinomas by differential display RT-PCR

被引:4
作者
Foca, C
Rice, GE
Quinn, MA
Moses, EK
机构
[1] Royal Hosp Women, Dept Perinatal Med, Perinatal Res Ctr, Carlton, Vic 3053, Australia
[2] Royal Hosp Women, Professorial Unit, Carlton, Vic 3053, Australia
[3] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic 3053, Australia
关键词
differential expression; endometrial carcinoma; endometrium; sequence analysis;
D O I
10.1093/molehr/6.8.712
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Differential display methodology was employed to examine and compare the mRNA species derived from normal endometrial tissue and endometrial carcinoma (grade 3, stage III) tissue biopsies. Two cDNA sequences, one expressed in the tumour group only (T19) and the other expressed only in the normal group (N22), were selected for verification of differential expression by semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR). The expression of N22 was restricted to the normal group, suggesting a possible tumour suppressing function. Sequence analysis of this fragment revealed a high degree of similarity to a human cDNA sequence of unknown function. The expression of T19 mRNA was observed in both normal and neoplastic tissues, however the relative abundance was significantly higher in endometrial carcinomas. Expression of T19 mRNA was further examined in a larger clinical sample set and was significantly increased in the tumours (n = 16), with a three-fold increase when compared with the normal endometria, n = 5 (Kruskal-Wallis analysis of variance, P < 0.05). Subsequent sequence analysis of T19 revealed a high degree of similarity to the 3' untranslated region of a rat growth factor responsive gene, SM-20. Further characterization of these mRNA transcripts may lead to the identification of novel genes involved in endometrial tumourogenesis.
引用
收藏
页码:712 / 718
页数:7
相关论文
共 19 条
[11]   Laparoscopic lymphadenectomy and vaginal or laparoscopic hysterectomy with bilateral salpingo-oophorectomy for endometrial cancer: Morbidity and survival [J].
Magrina, JF ;
Mutone, NF ;
Weaver, AL ;
Magtibay, PM ;
Fowler, S ;
Cornella, JL .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 181 (02) :376-381
[12]   Case-control study of endogenous steroid hormones and endometrial cancer [J].
Potischman, N ;
Hoover, RN ;
Brinton, LA ;
Siiteri, P ;
Dorgan, JF ;
Swanson, CA ;
Berman, ML ;
Mortel, R ;
Twiggs, LB ;
Barrett, RJ ;
Wilbanks, GD ;
Persky, V ;
Lurain, JR .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (16) :1127-1135
[13]   EXPRESSION OF RAS P21 ONCOPROTEIN IN NORMAL AND NEOPLASTIC HUMAN ENDOMETRIUM [J].
SCAMBIA, G ;
CATOZZI, L ;
BENEDETTIPANICI, P ;
FERRANDINA, G ;
BATTAGLIA, F ;
GIOVANNINI, G ;
DISTEFANO, M ;
PELLIZZOLA, D ;
PIFFANELLI, A ;
MANCUSO, S .
GYNECOLOGIC ONCOLOGY, 1993, 50 (03) :339-346
[14]  
SCAMBIA G, 1994, INT J CANCER, V56, P26
[15]  
Wax SD, 1996, LAB INVEST, V74, P797
[16]  
WAX SD, 1994, J BIOL CHEM, V269, P13041
[17]   Risk of endometrial cancer following estrogen replacement with and without progestins [J].
Weiderpass, E ;
Adami, HO ;
Baron, JA ;
Magnusson, C ;
Bergström, R ;
Lindgren, A ;
Correia, N ;
Persson, I .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (13) :1131-1137
[18]  
Westhof G, 1997, TUMORDIAGN THER, V18, P51
[19]   Value of glutathione S-transferase π and the oncogene products c-Jun, c-Fos, c-H-Ras, and c-Myc as a prognostic indicator in endometrial carcinomas [J].
Yokoyama, Y ;
Sagara, M ;
Sato, S ;
Saito, Y .
GYNECOLOGIC ONCOLOGY, 1998, 68 (03) :280-287